We are collecting annual survey topic proposals now through Friday, May 1, 2026. These topics, coupled with the annual staffing and center demographic questions, allow us to better understand your center and to share insights in publications.
When sharing your topics, please limit them to no more than 8 questions. Questions should be multiple choice; ranking and metric tables are suggested; free text is discouraged. To submit your topics please email qi@t1dexchange.org and cc nrioles@t1dexchange.org and crainey@t1dexchange.org with your ideas.
2026 Learning Session - Call for Abstracts!
T1D Exchange has opened the call for abstracts for the November Learning Session. We invite QI Collaborative centers to submit abstracts on both T1D and T2D topics.
Selected abstracts will be considered for publication in the Journal of Diabetes and for oral or poster presentations at the November Learning Session (November 10 & 11, 2026).
Please submit your abstract using the link below by July 31, 2026.
The submission link includes a list of topic areas of interest and guidance on Journal of Diabetes formatting requirements.
T1D Exchange values your involvement in the QI Collaborative! This survey will be used to evaluate engagement opportunities based on your level of participation and the value that they provide to your center. Please fill out the T1DX-QI Engagement Survey.
Additional Guidance for 2026-2028 Measures
These documents are intended for PIs and key diabetes center personnel who have a hand in reporting T1DX-QI data to T1D Exchange monthly. Our intent is to show you what has changed so that your center is able to report 2026-2028 for uniform benchmarking, and who can address your questions.
ATTD Highlights
Congratulations to Carla Demeterco-Berggren, MD, PhD, on presenting at ATTD last month. Her presentation, titled “Implementing Early-Stage Type 1 Diabetes Detection in Clinical Practice: Practical Insights from a U.S. Academic Pediatric Center,” highlighted the T1DX-QI’s goal to expand T1D screening, staging, and monitoring for individuals at higher risk of developing T1D.
Breakthrough T1D Clinical & Research Congress
The Breakthrough T1D Clinical & Research Congress (CRC 2026) abstract submission deadline is coming up on Wednesday, April 15.
CRC 2026 brings together an international community of professionals working on T1D discovery science, clinical care, and therapeutic advances.
The Congress offers an opportunity to present your work, engage with peers, and be part of an ongoing exchange in the field.
Check out a few of our recent publications using the links below:
DeLacey S, Rompicherla S, Grundman J, et al. Young Adult Diabetes Technology Use in Pediatric as Compared to Adult Practices. Endocrine Practice. 2026;32(1):11-15. doi:10.1016/j.eprac.2025.09.001
Kathryn L Fantasia, Stefanie Lanzinger, Saketh Rompicherla, Jennifer J Grammes, Grenye O’Malley, Julia K Mader, Lauren Golden, Florian Kopp, David M Maahs, Peter M Jehle, Osagie Ebekozien, Reinhard W Holl, Missed opportunities for risk reduction: type 1 diabetes management in older adults in DPV and T1DX-QI registries, Journal of the Endocrine Society, Volume 10, Issue 3, March 2026, bvag007, https://doi.org/10.1210/jendso/bvag007
Ashley N. Garrity, Jacqueline S. Fisher, Inas H. Thomas, Joyce M. Lee; Closing the Gap: Strategies for Broader Adoption and Use of Continuous Glucose Monitors Among Children and Adolescents With Type 1 Diabetes. Diabetes, Obesity, and Cardiometabolic CARE 11 February 2026; 1 (1): 40–44. https://doi.org/10.2337/doc25-0042
Iyengar J, Steenkamp D, Abdelhadi M, et al. It Is Time to Act: Making Diabetes Distress Screening Standard in Clinical Practice. Endocrine Practice. doi:10.1016/j.eprac.2026.01.011
.png?upscale=true&width=520&upscale=true&name=MicrosoftTeams-image%20(58).png)